Berberine Hcl Powder CAS 633-65-8

Antibacterial
Coptis chinensis, a traditional Chinese medicine, has the effect of clearing heat and detoxifying and has been used to treat diarrhea for thousands of years. Berberine has inhibitory effects on a variety of bacteria, but it is most effective against intestinal infections caused by dysentery bacillus and Escherichia coli. Therefore, it was first used as a commonly used drug for the treatment of gastroenteritis. Berberine hcl powder can fully exert its inhibitory effect on intestinal bacteria such as Shigella dysenteriae, Shigella fuciae, Salmonella and Staphylococcus aureus, while maintaining the homeostasis of the intestinal microenvironment and protecting the gastrointestinal mucosa, thereby addressing diarrhea caused by intestinal infections.

Reusing old medicine
Studies have found that Berberine hydrochloride and its derivatives have shown good performance in the treatment of hyperlipidemia, diabetes, arrhythmia, mental disorders, immune system diseases, Alzheimer's disease, hypertension, obesity, peptic ulcers, tumors and many other aspects, giving this old drug new life and prospects.

Hypoglycemic effect
Under the stimulation of glucose, Berberine hydrochloride can increase insulin secretion and cell proliferation in MIN6 islet cells, manifested as the effect of an insulin secretory promoter. Berberine hydrochloride can also activate the adenosine monophosphate-activated protein kinase signaling pathway to restore damaged pancreatic islet cells and promote insulin secretion in rats. Berberine hydrochloride can effectively inhibit the production of pro-inflammatory cytokines such as interleukin-6 and tumor necrosis factor -α, regulate the expression of insulin receptor substrate 1 and the phosphorylation of serine/threonine kinases, thereby improving the insulin signaling cascade and insulin resistance. It has the application prospect of assisting in controlling blood sugar.

Anti-inflammatory effect
Berberine hydrochloride can effectively inhibit the adhesion of white blood cells, suppress the activation of NF-κB, and the production and release of inflammatory factors such as TNF-α, IL-1β, IL-6, TGF-β, and IL-8.

Cardiovascular and cerebrovascular diseases
The new pharmacological effects of Berberine hydrochloride have been gradually discovered, and the discovery of these new effects also provides new possibilities for the future clinical application of Berberine hydrochloride. However, some new pharmacological effects of Berberine hydrochloride are still at the experimental research stage and lack clinical evidence. Therefore, whether these new pharmacological effects can eventually be widely recognized in clinical practice still requires further research.

Other
Berberine hydrochloride has been widely studied in the field of cardiovascular and cerebrovascular diseases. K+ channels, Ca+ channels, cholinesterase, M receptors, adenosine receptors, etc. can all become the targeted targets of the action of Berberine hydrochloride. Therefore, Berberine hydrochloride is also a lead compound with great research value and application prospects in the field of cardiovascular diseases.

Side effects
After the use of Berberine hydrochloride, it is absorbed very little by the blood, so the side effects are very small. The common side effects of berberine hydrochloride are constipation, and occasionally nausea, vomiting, rash and fever.